Neomycin,sulfate (salt),mixt. with (4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,- 4a,5,5a,6,11,12a-octahydro-3,6,10,12,12apentahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride and 3-[[(5-nitro-2-furanyl)methylene]amino]-2- oxazolidinone (59068-49-4)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 2-Naphthacenecarboxamide,7-chloro-4- (dimethylamino)-1,4,4a,5,5a,6,11,12aoctahydro- 3,6,10,12,12a-pentahydroxy-6- methyl-1,11-dioxo-,(4S,4aS,5aS,6S,12aS)-,mixt. with 3-[[(5-nitro-2-furanyl)methylene]- amino]-2-oxazolidinone and N-(5-nitro-2-thiazolyl)acetamide
- 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-,(4S,4aR,- 5S,5aR,6S,12aS)-,mixt. with 2-methyl-5-nitro-1H-imidazole-1-ethanol and 3-[[(5-nitro-2-furanyl)methylene]amino]- 2-oxazolidinone
- Vitamin E, mixt. with5,7-dichloro-8-quinolinol,(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamidemonohydrochloride and 3-[[(5-nitro-2-furanyl)methylene]amino]-2-oxazolidinone(9CI)
- Neomycin,sulfate (salt),mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride and 8-quinolinol sulfate (2:1) (salt)
- Arsonic acid,(4-aminophenyl)-,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide and 3-[[(5-nitro-2-furanyl)methylene]amino]-2- oxazolidinone
- Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione
- Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione
- Tylosin,phosphate (salt),mixt. with (4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,- 12,12a-pentahydroxy-6-methyl-1,11-dioxo- 2-naphthacenecarboxamide monohydrochloride
- 2-Naphthacenecarboxamide,N-[[4-[amino[(aminoiminomethyl)imino]methyl]-1-piperazinyl]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4S,4aS,5aS,6S,12aS)-
- 2-Naphthacenecarboxamide,N,N'-[1,2-ethanediylbis[(methylimino)methylene]]bis[4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4S,4'S,4aS,4'aS,5aS,5'aS,6S,6'S,12aS,12'aS)-
- D-Gluconic acid,calcium salt (1:1), mixt. with(4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide,3,4-didehydroretinol, (2R)-3,4-dihydro-2,5,7,8-tetramethyl
- Vitamin B12,mixt. with (4S,4aS,5aS,6S,12aS)-,7-chloro-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,- 12,12a-pentahydroxy-6-methyl-1,11-dioxo- 2-naphthacenecarboxamide
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,(4S,4aS,5aS,6S,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-N-[[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-6-methyl-1,11-dioxo-,(4S,4aS,5aS,6S,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrate (1:1), (4S,4aS,5aS,6S,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-,(4S,4aS,5aS,6S,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12apentahydroxy- 6-methyl-1,11-dioxo-8-(1- pyrrolidinylmethyl)-,(4S,4aS,5aS,6S,12aS)-
- 2-Naphthacenecarboxamide,4-(dimethylamino)-10-(b-D-galactopyranosyloxy)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,12,12a-tetrahydroxy-6-methyl-1,11-dioxo-,(4S,4aS,5aS,6S,12aS)-
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenylacetyl)- amino]- (2S,5R,6R)-,compounds,compd. with 2-(diethylamino)ethyl 4-aminobenzoate (1:1),mixt. with 4-amino-N-(4,6-dimethyl-2- pyrimidinyl)benzenesulfonamide and (4S,4aS,5aS,6S,12aS)-7-chloro-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,- 12,12a-pentahydroxy-6-methyl-1,11-dioxo- 2-naphthacenecarboxamide monohydrochloride
- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-